High-purity β-Nicotinamide Adenine Dinucleotide (β-NAD+, 500 mg) coenzyme reagent assayed for minimal nicotinamide/ADPR hydrolysis byproducts, designed for sirtuin deacetylase, PARP DNA-repair, and bioenergetic flux research.
Scientific Profile & Research Key Points: NAD+
High-purity β-Nicotinamide Adenine Dinucleotide (β-NAD+, 500 mg) coenzyme reagent assayed for minimal nicotinamide/ADPR hydrolysis byproducts, designed for sirtuin deacetylase, PARP DNA-repair, and bioenergetic flux research.
Active Batch Release Specifications (Lot SL-2026-148)
Analytical release verification for current NAD+ (500 mg) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-148 | 2026-10-28 | HPLC-UV + LC-MS (Small-Molecule Verification) | ≥99.2% (Chromatographic Peak) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile PBS (pH 6.0–7.0) or Bacteriostatic Water (adjust pH carefully for cell assays)
Temperature & Stability
Store lyophilized at -20°C dry; refrigerate reconstituted solutions at 2°C–8°C (hydrolyzes rapidly above 25°C).
NAD+ — Technical Questions & Answers
What is the molar concentration when reconstituting NAD+ (500 mg) in 2.0 mL?
Reconstituting the full 500 mg vial of NAD+ (MW 663.43 g/mol) in 2.0 mL of diluent produces a 250.00 mg/mL stock solution — equivalent to approximately 376.83 mM (376,830 µM) gross molarity before Net Peptide Content (NPC) adjustment.
How does NAD+'s salt form affect assay mass calculations?
NAD+ (CAS 53-84-9, formula C21H27N7O14P2) is supplied as Lyophilized free acid / buffered crystalline cake. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.
Which analytical methods verify NAD+ Lot SL-2026-148 and what pathway does it target?
Lot SL-2026-148 undergoes HPLC-UV + LC-MS (Small-Molecule Verification) confirming ≥99.2% (Chromatographic Peak) and identity against 663.43 g/mol. In preclinical literature, NAD+ targets Sirtuins (SIRT1–SIRT7), PARPs, CD38 & Mitochondrial Complex I (Covarrubias A.J. et al., Nat Rev Mol Cell Biol (2021) — NAD+ metabolism and its roles in cellular aging (PMID: 33353981)).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
GHK-Cu: Biochemistry of the Gly-His-Lys Copper Complex in Gene Expression and Tissue Remodeling
A biochemical review of the human tripeptide copper complex GHK-Cu. Epigenetic gene resetting, metalloproteinase modulation, collagen/elastin synthesis, and analytical HPLC verification.
Glutathione: The γ-Glutamyl Isopeptide Bond, Redox Potentials, and GSSG Dimerization
A molecular analysis of reduced Glutathione (GSH) vs oxidized Glutathione Disulfide (GSSG). Why the unusual gamma-peptide bond protects against intracellular peptidases.
MOTS-c: 16-Residue Mitochondrial-Derived Peptide, AMPK Activation, and Methionine Oxidation
Biochemistry of MOTS-c (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg). Mitochondrial open reading frame encoding, metabolic pathways, and Met-oxidation prevention.
Related Longevity & Cellular Biology Compounds
View category →